H2020Индивидуална стипендия2020–2025

SUPD · Sizing Up PD: Cavity-enhanced Characterisation of Single Biomarkers in Human Biofluids

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2020-11-02 → 2025-01-23
Финансиране от ЕС
289 733 €
Участници
2
Схема
MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Свойствата на единични протеини в течности се измерват чрез специални оптични кухини, без да се използват химически маркери. Технологията помага за по-добра диагностика на заболявания като Алцхаймер и Паркинсон чрез откриване на редки протеинови частици.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Sizing Up PD: Cavity-enhanced Characterisation of Single Biomarkers in Human Biofluids

Measurements on single biomolecules provide a perspective of exceptional detail, enabling understanding of the underlying molecular mechanisms that govern biological processes. Most commonly, single-molecule measurements employ fluorescence which often requires the chemical attachment of fluorescent labels. As well as being perturbative to biomolecules and their interactions, labels limit the achievable resolution and sensitivity through complex photophysics. Recent developments in single-molecule label-free Rayleigh scattering based approaches have enabled the determination of the molecular weight of single biomolecules down to 30 kDa, however these techniques require proximity to surfaces. Microscale optical fiber based Fabry-Pérot cavities (FFPCs) provide a fully integrated route towards high sensitivity, label-free single-molecule measurements in the solution-phase. In this work we exploit both the small mode volume and high Q-factor of high reflectivity biconcave FFPCs to measure the properties of single proteins down to 1 kDa as they undergo Brownian motion in aqueous solution with signal-to-noise-ratios of >100. Here we improve the limit of detection 30-fold and the temporal resolution 100-fold compared to the current state-of-the-art. With this label-free technique we are able to determine the hydrodynamic radii of single proteins with unprecedented sensitivity. This technology has the potential to be developed into a highly sensitive diagnostic tool for complex diseases such as Alzheimer's and Parkinson's which require detection of small rare protein species. This has substantial implications for medical sciences and the ability to develop drugs and therapies for complex diseases.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Parkinson’s disease is the most common movement disorder caused by neurodegeneration, for which there is no cure, no way of modifying the disease and no clinically accepted diagnostic tool. In the brain, the intrinsically disordered monomeric protein α-synuclein misfolds, aggregates and accumulates to form proteinaceous inclusions termed Lewy bodies. This process forms ‘oligomers’, intermediates in the aggregation pathway that are strongly implicated in the cellular toxicity that causes the disease. Oligomers are exceedingly challenging to study with traditional biophysical techniques because of their low abundance and variability in size, structure and stability. My research proposal aims to develop a new method capable of measuring the size and structural properties of single oligomers in human cerebral spinal fluid. By employing technologies in the field of cavity-enhanced spectroscopy and combining these with existing tools in single-molecule fluorescence I will investigate how the properties of oligomers in cerebral spinal fluid differ between healthy and Parkinson’s disease patients. In order to determine the molecular origins of Parkinson’s disease we need a comprehensive understanding of these pathogenic species. Achieving this goal will enable us to develop an early diagnostic tool which in turn will generate opportunities for therapeutic intervention.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз